Circulating biomarkers for prostate cancer.

Due to its significant applicability for early detection, risk prediction and follow-up evaluation, prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer patients. With the prevalent use of PSA for early detection during the last two decades, disease characteristics...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Steuber, T, Helo, P, Lilja, H
פורמט: Journal article
שפה:English
יצא לאור: 2007